mepivacaine has been researched along with ro13-9904 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brander, KA; Frutig, K; Hari, Y; Pichler, WJ; Schnyder, B; Valitutti, S; von Greyerz, S; Zanni, MP | 1 |
1 other study(ies) available for mepivacaine and ro13-9904
Article | Year |
---|---|
HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.
Topics: Antigen Presentation; Antigen-Presenting Cells; Calcium Signaling; Ceftriaxone; Dose-Response Relationship, Drug; Down-Regulation; Haptens; HLA Antigens; Humans; Lidocaine; Mepivacaine; Models, Immunological; Receptors, Antigen, T-Cell, alpha-beta; Sulfamethoxazole; Superantigens; T-Lymphocytes | 1998 |